A snapshot of antimicrobial resistance in Mexico. Results from 47 centers from 20 states during a six-month period

摘要: Aim We aimed to assess the resistance rates of antimicrobial-resistant, in bacterial pathogens epidemiological importance 47 Mexican centers. Material and methods In this retrospective study, we included a stratified sample centers, covering 20 states. Selected isolates considered as potential causatives disease collected over 6-month period were included. Laboratories employed their usual perform microbiological studies. The results deposited into database analyzed with WHONET 5.6 software. Results total 22,943 strains Regarding Gram-negatives, carbapenem was detected ≤ 3% Escherichia coli, 12.5% Klebsiella sp. Enterobacter sp., up 40% Pseudomonas aeruginosa; latter, rate for piperacillin-tazobactam (TZP) high 19.1%. In Acinetobacter cefepime, ciprofloxacin, meropenem, TZP higher than 50%. Gram-positives, methicillin Staphylococcus aureus (MRSA) 21.4%, vancomycin (VAN) reached 21% Enterococcus faecium. presented highest multidrug (53%) followed by (22.6%) E. coli (19.4%). Conclusion The specific groups enterobacteria deserve special attention Mexico. Vancomycin-resistant enterococci (VRE) MRSA are common our hospitals. Our present valuable information implementation measures control drug resistance.